{"id":163987,"date":"2022-11-05T01:42:14","date_gmt":"2022-11-05T05:42:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/adverum-biotechnologies-presents-positive-end-of-study-results-from-the-optic-trial-in-wet-amd-including-two-year-outcomes-following-a-single\/"},"modified":"2024-08-18T11:45:39","modified_gmt":"2024-08-18T15:45:39","slug":"adverum-biotechnologies-presents-positive-end-of-study-results-from-the-optic-trial-in-wet-amd-including-two-year-outcomes-following-a-single","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/adverum-biotechnologies-presents-positive-end-of-study-results-from-the-optic-trial-in-wet-amd-including-two-year-outcomes-following-a-single.php","title":{"rendered":"Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single&#8230;"},"content":{"rendered":"<p><![CDATA[- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead to stable and persistent aflibercept protein levels through three years in participants in the OPTIC extension study]]><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/11\/04\/2548969\/0\/en\/Adverum-Biotechnologies-Presents-Positive-End-of-Study-Results-from-the-OPTIC-Trial-in-Wet-AMD-Including-Two-Year-Outcomes-Following-a-Single-Intravitreal-Injection-of-Ixo-vec-ADVM.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single...\">Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The rest is here: Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/adverum-biotechnologies-presents-positive-end-of-study-results-from-the-optic-trial-in-wet-amd-including-two-year-outcomes-following-a-single.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163987","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163987"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163987"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163987\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}